Folate Receptor-Targeted and GSH-Responsive Carboxymethyl Chitosan Nanoparticles Containing Covalently Entrapped 6-Mercaptopurine for Enhanced Intracellular Drug Delivery in Leukemia

Abstract

For enhanced intracellular accumulation of 6-mercaptopurine (6-MP) in leukemia, a folate receptor-targeted and glutathione (GSH)-responsive polymeric prodrug nanoparticle was made. The nanoparticles were prepared by conjugating 6-MP to carboxymethyl chitosan via a GSH-sensitive carbonyl vinyl sulfide linkage, ultrasonic self-assembly and surface decoration with folate. The TEM graphs shows that the as-synthesized nanoparticles are spherical with a particle size of 170~220 nm. In vitro drug release of nanoparticles demonstrated acceptable stability in PBS containing 20 μM GSH at pH 7.4. However, the cumulative drug release rate of the samples containing 20 mM and 10 mM GSH medium reached 78.9% and 64.8%, respectively, in pH 5.0 at 20 h. This indicated that this nano-sized system is highly sensitive to GSH. The inhibition ratio of folate-modified nanoparticles compared to unmodified nanoparticles was higher in cancer cells (human promyelocytic leukemia cells, HL-60) while their cytotoxicity was lower in normal cells (mouse fibroblast cell lines, L929). Furthermore, in vitro cancer cell incubation studies confirmed that folate-modified nanoparticles therapeutics were significantly more effective than unmodified nanoparticles therapeutics. Our results suggest that folate receptor-targeting and GSH-stimulation can significantly elevate tumour intracellular drug release. Therefore, folate-modified nanoparticles containing chemoradiotherapy is a potential treatment for leukemia therapy.

Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations

“…DOF is one important tool in employing quality by design in formulation development [ 43 ]. Latterly, the use of micro/nanoparticles has gained more attention in targeted drug delivery, showing high drug availability and treatment efficacy for many diseases such as cancer, skin disease, a neurodegenerative disorder, and inflammatory diseases [ 44 , 45 , 46 , 47 ]. Likewise, polymer-based micro/nanocapsules have a particular interest in controlled and targeted drug delivery [ 48 ].…”

Nanomagnetite-embedded PLGA Spheres for Multipurpose Medical Applications

“…The incorporation of magnetic nanoparticles into biopolymeric microspheres represents an attractive strategy for modern pharmacotherapy, since the additional functionality relies on guiding nanostructured spheres with an external magnetic field gradient and triggering the release of bioactive compounds [51,52]. The applications of magnetic nanoparticle–embedded microspheres include detection and diagnosis by magnetic resonance imaging, and local pharmacological effect by subjecting the nanostructured microspheres to magnetic hyperthermia [53,54,55]. Following the exposure of such nanostructured platforms to external high amplitude alternating magnetic field, targeted and controlled drug delivery may be achieved.…”

Recent advances of drug delivery nanocarriers in osteosarcoma treatment

“…Folate is an ideal candidate for ligand-based targeted therapy, as numerous examples of folate receptor-targeted drug delivery carriers have been reported to transport anticancer drugs into cells through receptor mediated endocytosis 118, 119. The overexpression of the folate receptor has been reported in many osteosarcoma xenograft samples 120.…”